Last update 03 Dec 2024
Lomedeucitinib
Last update 03 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms BMS 986322, BMS-986322 |
Target |
Mechanism TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC18H20N6O4S |
InChIKeyVWIVBQZLVAGLMH-ASGODXDTSA-N |
CAS Registry2328068-29-5 |
Related
6
Clinical Trials associated with LomedeucitinibA Phase 1, Single-center, Open-label Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of [14C] BMS-986322 in Healthy Adult Male Participants
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Study to Evaluate the Clinical Efficacy and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
An Open-Label, Single-Sequence Crossover, Drug-Drug Interaction Study to Assess the Effect of Steady-State BMS-986322 on the Pharmacokinetics of Rosuvastatin (Part 1), the Pharmacokinetics and Pharmacodynamics of Metformin (Part 2) and the Pharmacokinetics of Methotrexate (Part 3) in Healthy Participants
100 Clinical Results associated with Lomedeucitinib
Login to view more data
100 Translational Medicine associated with Lomedeucitinib
Login to view more data
100 Patents (Medical) associated with Lomedeucitinib
Login to view more data
100 Deals associated with Lomedeucitinib
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Psoriasis | Phase 2 | US | 03 Apr 2023 | |
| Psoriasis | Phase 2 | JP | 03 Apr 2023 | |
| Psoriasis | Phase 2 | AU | 03 Apr 2023 | |
| Psoriasis | Phase 2 | CA | 03 Apr 2023 | |
| Psoriasis | Phase 2 | GB | 03 Apr 2023 | |
| Autoimmune Diseases | Phase 1 | US | 30 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free